SecBot SecBot
8-K ·Filed May 11, 2026

MOH

MOLINA HEALTHCARE, INC.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001179929-26-000026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

The low say-on-pay approval (53%) signals shareholder discontent with executive compensation, which may lead to future proxy fights or board engagement. Monitor next earnings call for management's response and any changes to compensation structure. The special meeting right, while granted, has high thresholds and is unlikely to be used in the near term.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$184.46
T+0 close · May 11, 2026 · via day close
Latest settled
+5.63%
T+60 · $194.84
Vs SPY
+1.50%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 11 $184.46entry
  2. T+1 · 6mo ago +3.75%α +3.88% · $191.37
  3. T+5 · 6mo ago +0.10%α +0.19% · $184.65
  4. T+20 · 5mo ago +10.08%α +10.39% · $203.06
  5. T+60 · 3mo ago +5.63%α +1.50% · $194.84

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Molina Healthcare filed an 8-K reporting results of its 2026 Annual Meeting. All 10 director nominees were elected, and all five stockholder proposals passed. Notably, the say-on-pay proposal received only 53% support (22.5M for, 20.1M against), indicating significant shareholder dissatisfaction. The equity incentive plan shares were increased by 1.5 million to 3.295 million shares, and the certificate of incorporation was amended to allow stockholders with at least 20% voting power to call special meetings (subject to procedural requirements). These are routine governance updates with no immediate financial impact.

Key Facts

  • Annual meeting held on May 6, 2026; 90.55% of shares represented.
  • All 10 director nominees elected; Ronna E. Romney received the most against votes (4.0M).
  • Say-on-pay proposal passed with 52.8% support (22.5M for vs 20.1M against).
  • Equity incentive plan amendment approved: shares increased by 1.5M to 3.295M.
  • Certificate of incorporation amended to allow 20% holders to call special meetings.
  • Bylaws amended and restated with special meeting procedures and proxy access provisions.

Financial Impact

Minor potential dilution from the 1.5M share increase; no material financial magnitude.

dilution

Risk Factors

  • Potential shareholder activism or proxy contest due to low say-on-pay support.
  • Increased dilution from the expanded equity plan (1.5M additional shares).

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
29% bullish (24 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001179929-26-000026
Exhibit: exhibit31_certificateofame.htm0001179929-26-000026
Exhibit: exhibit101_amendmentnumber.htm0001179929-26-000026
Document: moh-20260506.htm0001179929-26-000026
Document: 0001179929-26-000026-index-headers.html0001179929-26-000026
Document: 0001179929-26-000026-index.html0001179929-26-000026
Document: 0001179929-26-000026.txt0001179929-26-000026

US Market Status

Market Closed · Opens in 7h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026